PT3283171T - Derivados de anfotericina b - Google Patents

Derivados de anfotericina b

Info

Publication number
PT3283171T
PT3283171T PT167808138T PT16780813T PT3283171T PT 3283171 T PT3283171 T PT 3283171T PT 167808138 T PT167808138 T PT 167808138T PT 16780813 T PT16780813 T PT 16780813T PT 3283171 T PT3283171 T PT 3283171T
Authority
PT
Portugal
Prior art keywords
amphotericin
derivatives
Prior art date
Application number
PT167808138T
Other languages
English (en)
Portuguese (pt)
Original Assignee
Sfunga Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sfunga Therapeutics Inc filed Critical Sfunga Therapeutics Inc
Publication of PT3283171T publication Critical patent/PT3283171T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PT167808138T 2015-04-15 2016-04-15 Derivados de anfotericina b PT3283171T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562147949P 2015-04-15 2015-04-15

Publications (1)

Publication Number Publication Date
PT3283171T true PT3283171T (pt) 2021-07-14

Family

ID=57126898

Family Applications (1)

Application Number Title Priority Date Filing Date
PT167808138T PT3283171T (pt) 2015-04-15 2016-04-15 Derivados de anfotericina b

Country Status (7)

Country Link
US (3) US9957290B2 (enExample)
EP (2) EP3929203A1 (enExample)
JP (3) JP7240811B2 (enExample)
CA (2) CA3213127A1 (enExample)
ES (1) ES2880029T3 (enExample)
PT (1) PT3283171T (enExample)
WO (1) WO2016168568A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102548341B1 (ko) 2013-10-07 2023-06-26 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 개선된 치료 지수를 갖는 암포테리신 b 유도체
MX378786B (es) 2014-06-12 2025-03-11 Shionogi & Co Derivado de macrólido de polieno.
PT3283171T (pt) * 2015-04-15 2021-07-14 Sfunga Therapeutics Inc Derivados de anfotericina b
WO2017100171A1 (en) * 2015-12-08 2017-06-15 Kalyra Pharmaceuticals, Inc. Antifungal compounds and methods
WO2018106571A1 (en) * 2016-12-06 2018-06-14 Kalyra Pharmaceuticals, Inc. Antifungal compounds and methods
CN113056274A (zh) * 2018-09-07 2021-06-29 伊利诺伊大学评议会 具有降低的毒性的杂化两性霉素b衍生物
EP4009984A4 (en) * 2019-08-08 2023-09-06 The Board Of Trustees Of The University Of Illinois HYBRID AMPHOTERICIN B DERIVATIVES WITH REDUCED TOXICITY
AU2020325163B2 (en) * 2019-08-08 2026-04-23 The Board Of Trustees Of The University Of Illinois Hybrid amide derivatives of amphotericin B
FR3112145A1 (fr) * 2020-07-03 2022-01-07 Nanotracks Diagnostics Derives uree de macrolides polyeniques, composes chimiques particuliers susceptibles d’etre utilises pour obtenir ces derives uree, compositions les contenant et utilisations
WO2022003181A1 (fr) * 2020-07-03 2022-01-06 Nanotracks Diagnostics Derivés urée de l'amphotéricine amb, compositions les contenant et leurs utilisations, dérivés isocyanate d'alkyle omega-aminés et leur utilisation pour obtenir lesdits dérivés urée
AU2021325676A1 (en) * 2020-08-10 2023-03-30 The Board Of Trustees Of The University Of Illinois Hybrid amide derivatives of amphotericin B

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0350164A3 (en) * 1988-06-13 1991-07-24 Beecham Group Plc Amphotericin derivatives
GB8829592D0 (en) 1988-12-19 1989-02-08 Beecham Group Plc Novel compounds
EP0431870A1 (en) 1989-12-08 1991-06-12 Beecham Group p.l.c. Amphotericin B derivatives
JP3507486B2 (ja) 1991-03-15 2004-03-15 アムジエン・インコーポレーテツド 顆粒球コロニー刺激因子の肺内投与
GB9203476D0 (en) 1992-02-19 1992-04-08 Smithkline Beecham Plc Novel compounds
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
US5606038A (en) 1995-04-10 1997-02-25 Competitive Technologies, Inc. Amphiphilic polyene macrolide antibiotic compounds
PL180253B1 (pl) * 1995-05-13 2001-01-31 Politechnika Gdanska Pochodne N-metylo-N-glikozylowe estrów metylowych antybiotyków z grupy makrolidów polienowych i ich sole oraz sposób ich otrzymywania PL PL PL PL PL PL
US6664241B2 (en) 2000-05-31 2003-12-16 Micrologix Biotech Inc. Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof
US20090186838A1 (en) * 2006-02-23 2009-07-23 Eidgenössische Technische Hochschule Zürich Amphotericin Derivatives
JP5240704B2 (ja) * 2007-10-05 2013-07-17 国立大学法人群馬大学 新規蛍光化合物およびそれを用いた細胞内コレステロールの検出方法
JP2015519389A (ja) 2012-06-15 2015-07-09 ブリート スポルカ アクシヤ 抗真菌性抗生物質アンフォテリシンbのn−置換第二世代誘導体ならびにそれらの調製および塗布方法
WO2014165676A1 (en) 2013-04-03 2014-10-09 The Board Of Trustees Of The University Of Illinois Amphotericin b derivative with reduced toxicity
KR102548341B1 (ko) * 2013-10-07 2023-06-26 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 개선된 치료 지수를 갖는 암포테리신 b 유도체
WO2015164289A1 (en) * 2014-04-21 2015-10-29 Cidara Therapeutics, Inc. Compositions and methods for the treatment of fungal infections
JP6543272B2 (ja) 2014-05-16 2019-07-10 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイThe Board Of Trustees Of The University Of Illinois 低減された毒性を有するアンホテリシンb誘導体
MX378786B (es) * 2014-06-12 2025-03-11 Shionogi & Co Derivado de macrólido de polieno.
WO2016014779A1 (en) 2014-07-23 2016-01-28 The Board Of Trustees Of The University Of Illinois Antifungal polyene macrolide derivatives with reduced mammalian toxicity
WO2016040779A1 (en) 2014-09-12 2016-03-17 The Board Of Trustees Of The University Of Illinois Urea derivatives of polyene macrolide antibiotics
ES3072651T3 (en) 2014-10-17 2026-07-03 Univ Illinois Scalable synthesis of reduced toxicity derivative of amphotericin b
JP6726192B2 (ja) 2015-01-08 2020-07-22 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイThe Board Of Trustees Of The University Of Illinois アムホテリシンbの尿素誘導体の簡便な合成法
WO2016112243A1 (en) 2015-01-08 2016-07-14 The Board Of Trustees Of The University Of Illinois Urea derivatives of amphotericin b derived from secondary amines
PT3283171T (pt) * 2015-04-15 2021-07-14 Sfunga Therapeutics Inc Derivados de anfotericina b

Also Published As

Publication number Publication date
EP3929203A1 (en) 2021-12-29
CA3213127A1 (en) 2016-10-20
HK1244248A1 (zh) 2018-08-03
EP3283171A4 (en) 2019-03-13
EP3283171A1 (en) 2018-02-21
EP3283171B1 (en) 2021-05-26
US10597420B2 (en) 2020-03-24
US10882883B2 (en) 2021-01-05
WO2016168568A1 (en) 2016-10-20
CA3021061C (en) 2023-10-24
JP2021075570A (ja) 2021-05-20
CA3021061A1 (en) 2016-10-20
US20180273572A1 (en) 2018-09-27
ES2880029T3 (es) 2021-11-23
US9957290B2 (en) 2018-05-01
JP7240811B2 (ja) 2023-03-16
US20160304548A1 (en) 2016-10-20
JP2018514522A (ja) 2018-06-07
JP2023030103A (ja) 2023-03-07
US20200262858A1 (en) 2020-08-20

Similar Documents

Publication Publication Date Title
SG11201706729SA (en) Derivatives of sobetirome
ZA201800826B (en) Substituted oxopyridine derivatives
IL257026A (en) Solid state forms of eluxadoline
IL253381B (en) History of h9–pyrrolo–dipyridine
SMT202100551T1 (it) Derivati di sobetirome
SI3524234T1 (sl) Trdne oblike sofosbuvira
SG11201609205WA (en) Heterocyclyl-butanamide derivatives
PT3334734T (pt) Forma c de avibactam sódico
PL3164393T3 (pl) Pochodne flawaglin
HUE050450T2 (hu) Fluoralkil-fluorén-származékok
SI3380554T1 (sl) Kristalne oblike per-kloro-gama-ciklodekstrinov
SG10202101979TA (en) Crystalline forms of c21h22ci2n4o2
IL246979A0 (en) Crystalline forms of sofosbuvir
IL248773A0 (en) History of naphthyridinedione
IL251005B (en) Pyrido-oxazinone derivatives
ZA201706282B (en) Solid forms of menaquinols
GB201604627D0 (en) Improved method of FT-IMS
PL3119744T3 (pl) Pochodne 2-cyjano-3-cyklopropylo-3-hydroksy-N-arylo-tioakryloamidu
AP2016009530A0 (en) Cycloalkyl-linked diheterocycle derivatives
IL253479A0 (en) Crystalline forms of efinconazole
IL249130A0 (en) Preparation of piperidine-4-carbthioamide
SG11201804610RA (en) Marking-out aid
HUP1500506A2 (en) Salts of palbociclib
IL249332A0 (en) Crystalline forms of sofosbuvir
PH32015000758S1 (en) Set of earbuds